Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Excelera ACO is a U.S. healthcare services and technology company focused on value-based care for Medicare beneficiaries rather than a drug-development biotech company. The organization operates an accountable care organization model and provides physicians with contracting vehicles, care-management infrastructure, analytics, and AI-enabled clinical insights to improve quality and lower cost of care. Public materials describe Excelera as using its Human Insights platform, which combines machine learning, genomics, and other data sources to support prevention and chronic disease management. Excelera has participated in CMS accountable care programs, including the Medicare Shared Savings Program and the Direct Contracting/ACO REACH framework, with operations centered in California and Hawaii. The business appears to be commercial-stage and service-oriented, with no disclosed therapeutic pipeline in the conventional biotech sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Excelera ACO.